Retham Technologies aims to improve the diagnosis of Heparin induced thrombocytopenia (HIT) by providing rapid and accurate testing solutions. Their focus is on enabling healthcare professionals to better manage patient care through reliable diagnostic methods.
Founded
2017
Total Funding
$1M+
Total Rounds
1
First Raise
Sep 15, 2026
Latest Raise
Sep 15, 2026
New funding rounds in your inbox every week 路 No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 9/15/2026 | |||
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week 路 Free